- Home
- ADMA vs AVPT Comparison
ADMA vs AVPT Comparison
Compare ADMA & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- AVPT
- Stock Information
- Founded
- ADMA 2004
- AVPT 2001
- Country
- ADMA United States
- AVPT United States
- Employees
- ADMA N/A
- AVPT 2543
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- AVPT Computer Software: Prepackaged Software
- Sector
- ADMA Health Care
- AVPT Technology
- Exchange
- ADMA Nasdaq
- AVPT Nasdaq
- Market Cap
- ADMA 3.8B
- AVPT 3.6B
- IPO Year
- ADMA N/A
- AVPT N/A
- Fundamental
- Price
- ADMA $16.90
- AVPT $19.12
- Analyst Decision
- ADMA Strong Buy
- AVPT Buy
- Analyst Count
- ADMA 4
- AVPT 5
- Target Price
- ADMA $21.25
- AVPT $15.00
- AVG Volume (30 Days)
- ADMA 2.5M
- AVPT 1.1M
- Earning Date
- ADMA 02-26-2025
- AVPT 02-27-2025
- Dividend Yield
- ADMA N/A
- AVPT N/A
- EPS Growth
- ADMA N/A
- AVPT N/A
- EPS
- ADMA 0.28
- AVPT N/A
- Revenue
- ADMA $382,809,000.00
- AVPT $315,923,000.00
- Revenue This Year
- ADMA $66.90
- AVPT $23.58
- Revenue Next Year
- ADMA $13.76
- AVPT $18.51
- P/E Ratio
- ADMA $60.29
- AVPT N/A
- Revenue Growth
- ADMA 63.39
- AVPT 21.13
- 52 Week Low
- ADMA $5.02
- AVPT $7.08
- 52 Week High
- ADMA $23.64
- AVPT $19.20
- Technical
- Relative Strength Index (RSI)
- ADMA 48.60
- AVPT 66.56
- Support Level
- ADMA $15.70
- AVPT $18.12
- Resistance Level
- ADMA $16.60
- AVPT $19.20
- Average True Range (ATR)
- ADMA 0.69
- AVPT 0.64
- MACD
- ADMA 0.10
- AVPT 0.15
- Stochastic Oscillator
- ADMA 77.17
- AVPT 96.68
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.